Abingworth LLP 13D and 13G filings for Verona Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-08-11 4:54 pm Purchase |
2022-04-29 | 13D | Verona Pharma plc VRNA |
Abingworth LLP | 21,313,822 4.400% |
249,600![]() (+1.18%) |
Filing |